This is a Brave Rewards publisher verification file. Domain: Token: 6398373f459ee8aac7e7ee92eca2f16fa5e2713cfbed3100d69b07a69f6177c1 google-site-verification=OIFzd9VZmCKIIkdj8kgelmd1b_GxU-xz2VhUumtQFCM, pub-2516799717020337, DIRECT, f08c47fec0942fa0

Oppenheimer Maintains Buy Ratings For CBAY Price Target $19

Oppenheimer Maintains a Buy Rating on CymaBay Therapeutics (CBAY)

Oppenheimer has a price target for CBAY at $19. Not so fast. The price chart is displaying it will not make it that high. The price chart is showing a price target of $10 - $12, maybe $14.

1 view0 comments